# Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.

> **NCT04862377** · PHASE3 · UNKNOWN · sponsor: **Hospital Clinic of Barcelona** · enrollment: 50 (estimated)

## Conditions studied

- Bronchopulmonary Dysplasia
- Respiratory Distress Syndrome in Premature Infant
- Prematurity

## Interventions

- **DRUG:** Poractant Alfa Intratracheal Suspension [Curosurf]
- **DRUG:** Budesonide 0.5 MG/ML

## Key facts

- **NCT ID:** NCT04862377
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04862377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04862377, "Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04862377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*